gically characterized in 1894 by Krtiger, who identified them as fungi on account of their cultural similarity to yeasts (Kriiger, 1894) . The organisms were identified as algae in 1913 due to their ability to sporulate similarly as Chlorella species, and reclassified three years later by West (West, 1916) to the genus Prototheca, family Chlorelaceae. Prototheca is an achlorophyllous mutant of the green algae with nonfunctional chloroplast. Achlorophyllous mutants of Chlorellae have been successfully produced in the laboratory; although the pathway of their genesis in natural environment still remains unclear (H u s s and S o g i n, 1990). Until now, five species have been generally recognized within the genus: P. wickerhamii, P. zopfii, P. moriformis, P. ulmea and P. stagnora.
DISTRIBUTION
Prototheca spp. is ubiquitous in nature and widely distributed all over the world. The organism had first been isolated from the slime flux of trees and over the following decades from a wide variety of sources including sewage, soil, plants and many fresh and salt water sources, even from water-supply systems (Anderson and Walker, 1998; Pore et al., 1983 , Walsh et al., 1998 . The organism is particularly predominant in aqueous locales containing decomposing plant material. Prototheca spp. were isolated from skin scarificates, sputum and feces of humans in absence of infection (S o n c k and Koch, 1971) , as well as in a variety of domestic and some wild animals. Occurrence of the organism in the feces of cattle, pig, horses and sheep is associated with the use of contaminated feed.
Life cycle and morphological traits
Prototheca spp. are monocellular organisms, oval or spherical in shape, 7-16 urn in diameter (Anderson and Walker, 1998; Di Persio, 2001) . They differ from bacteria and yeasts in size, shape and reproductive characteristics. Contrary to yeasts and bacteria they do not have glucosamine in their cell wall and do not contain muraminic acid, respectively (D i Persio, 2001 ). The cell wall of Protothecae consists of outer (thinner) and inner (thicker) envelope, while all Chlorella species (except for Ch. prototecoides) are characterized by a three-layer cell wall (S udm an, 1974) . The three species commonly isolated from the natural environment are considered non-pathogenic, i. e., P. stagnora, P. ulmea and P. moriformis. These species are able to produce capsule (similarly to Cryptococcus neoformans); however, this feature was not observed in any of clinical isolates of P. wickerhamii and P. zopfii (D i Persio, 2001 ). The reproduction is asexual, by internal septation and endospore formation. The sporangia contain 2-16 or more daughter-cells (sporangiospores), which, following the characteristic cell-wall breakage, further develop the endosporulating cells (Pore, 1998) .
Prototheca spp. as causative agent of infection
Of the five known species of the genus, only P. wickerhamii and P. zopfli are considered pathogenic, yet their pathogenic potential is low. Until now, they are the only known plant causative agent of human and animal infections (R o e s 1 e r et al., 2003) .
Human protothecoses
The first case of human protothecosis was described by D a v i e s et al. in 1964, manifested as localized skin lesions in a farmer in Sierra Leone, while the first systemic protothecosis was described by Cox et al. in 1974. Over the past 25 years, medical references reported on more than 100 cases of human protothecoses, mostly induced by P. wickerhamii and rarely by P. zopfii (Krcmery, 2000; Monopoli et al., 1995; Wirth, 1999) . Though unfrequent, protothecal infections are reported worldwide: in Europe, Asia, Africa and Central America. In our country, the first isolation of Prototheca spp. from clinical material was reported on April 5, 2005 by the Serbian Microbiology Association, Section of Vojvodina (Suvajdžić, 2005) . Infections occur in all age categories, but extremely rarely in the pediatric population.
Described as environment-borne agent, Prototheca spp. enter the body via the traumatic skin lesion and mucous membranes, on subsequent exposure to contaminated water. Human-human transmission route is excluded. The incubation period has not been precisely defined yet; however, anamnestic data on post-traumatic infection suggest a 2-week incubation period.
Some 50% of all reports on human protothecoses relate to localized cutaneous infections, slowly-developing single or multiple lesions that do not heal spontaneously. They are described as diffuse erythema, papulae, vesico-pustules, ulcerations, nodous, eczematous or herpetiform changes located mostly on extremities. Pain and swelling of soft tissues may occur, as well as various quantities of serous-sanguineous liquid. Regional lymph nodes are rarely affected. Failure of prompt diagnosis of cutanous protothecosis may result in the development of chronic destructive lesions even in immunocompetent individuals. The second most frequent form of protothecosis is olecranon bursitis, which develops as a consequence of traumatic implantation of the agent. It is manifested as induration of the bursa, associated by swelling and moderate erythema (G a 1 a n et al., 1997). The rarest and most severe form of the infection is disseminated or systemic protothecosis, described in patients with durable course of primary disease or immune dysfunction (diabetes mellitus, malignancy and chemotherapy, renal transplantation, systemic lupus erythematosus, corticosteroid therapy and HIV infection) (Kunova et al., 1996) .
Animal protothecoses
In veterinary medicine, Prototheca zopfli and rarely also P. wickerhamii are reported as causative agents of cutaneous protothecosis in dogs and cats, systemic protothecosis in dogs and mastitis in dairy cows (Gonzales, 1996 , Monopoli et al., 1995 .
Dogs and cats
Cutaneous protothecosis induced by P. wickerhamii is the only disease manifestation described in cats (Dillberger et al., 1988) . In both cats and dogs, the cutaneous form results from injury infection and is manifested by the occurrence of ulcerative lesions, scabs and pyogranulomatous dermatitis in limbs, trunk and mucous surfaces. Hyperkeratosis may develop too, and frequent complications are due to secondary bacterial infections. Pathohistological examination of skin bioptates reveals abundant protothecal organisms within the cytoplasm of phagocytic cells (Gin el et al., 1997) .
In systemic protothecosis in dogs it is most likely that algae enter the body by ingestion, passing the intestinal mucosa (infection portal) and disseminating to the entire body via the hematogenic and lymphogenic routes (Hoi-1 i n g s w o r t, 2000). Systemic prorothecosis in dogs is mostly induced by P. zopfii, rarely by P. wickehamii, and disease symptoms depend on the organs and organ-systems affected, as well as on the severity of the lesions. Unremarkable and unspecific symptoms mostly result in delayed diagnosis, enabling the agent to spread over the entire body. Even in systemic infections only cutaneous manifestations, symptoms of gastro-intestinal disorders and eye infection were clinically manifested (Hollingswort, 2000; Ginel et al.. 1997) .
Numerous reports have indicated gastrointestinal disorders as most frequent clinical signs of disseminated protothecosis. M i g a k i et al. (1982) described hemorrhagic colitis in dogs induced by P. zopfii. The colon is the most severely affected site, but lesions are visible over the entire intestine. Clinical manifestation of the disease includes vomiting, tenesmus and intermittent diarrhea (blood and slime in the feces). Colonoscopy reveals diffuse hyperemia, hemorrhages and ulcerations, as well as multiple granuloma of the mucosa, which, in the further course of the disease, results in intestinal stricture and obstipation.
The infection can spread to the central nervous system, cardio-vascular system and urinary tract, liver, skeletal muscles, lymph nodes, thyroid gland, pancreas, peritoneum and diaphragm (Hollingswort, 2000) . Infection of the eye is common manifestation of systemic protothecosis in dogs. It results in severe damages and blindness that are due to development of glaucoma and retinal ablation. Protothecae are identified by microscopy examination of humor vitreus (S c h u 11 z e et al., 1998). Manifest signs of disease in CNS (cervical pain, depression, ataxia, pareses) are rare. The affected organs exhibit typical reaction to protothecal infection, i.e., formation of granulomes 0.5-2 mm in diameter with the cell infiltrate composed of cell plasma, macrophages and neutrophiles.
Bovine mastitis
Prototheca was first linked to mastitis by Lerch in 1952, Mastitis in dairy cows is mostly induced by P. zopfii, sometimes by P. wickerhamii (G o nzales, 1996; Janosi et a)., 1998). P. zopfii mastitis is a disease of highly productive cows in the machine-milking systems. Although it mostly occurs sporadically, endemic events are also reported (Janosi et al., 2000) . (Anderson and Walker, 1998; Schlendstedt et al., 1997; Tenhagen et al., 1999) . Outbreaks of seasonal protothecal mastitis have been reported during warm and humid periods of the year that promote the propagation of these organisms in their natural habitat (Cost a et al., 1996) .
Infection commences at the papillae of mammary glands in all lactation phases, including dry period (www.Uvex.edu/miklquality/prototheca). In the first weeks of lactation an increased susceptibility to infection was observed, which is due to the pronounced energetic misbalance (Costa et al., 1997) . The infective dose is not yet defined. In experimental conditions, infusion of 40-480 CPU P. zopfii results in mastitis in 100% cases. Five days after the experimental infection the alga can be isolated from milk in a yield 20 000-50000 CFU/ml (McDonald et al., 1984a) . Anticipated infective doses for natural infection are high in comparison with other mastitis agents. This quantity is provided through permanent contact of teeth ends with the primary infection sources such as soil, plants, water sources and feces. A common infection source is improper sanitation before the mastitis treatment, since the organism may be introduced via the infusion material, similar as Nocardia species. Furthermore, cow-to-cow infection during milking is also possible (A nd e r s o n and Walker, 1998; Dion, 1979) . Prototheca spp. have been recovered from the rubber parts of milking equipment and they showed height resistance to routine disinfection with chlorine solutions (Anderson and Walker, 1998; Costa et al., 1997) . Despite the observed mixed infections with Staphylococcus aureus and Streptococcus spp., synergy of P. zopfii and other bacteria pathogenic for bovine udder was not confirmed (S c hi e nsted et al., 1997).
Protothecal infections result in chronic manifest subclinical and clinical mastitis without signs of systemic infection (fever, depression) (Tenhagen et al., 1999) . Compared with mastitis forms of other etiologies, the inflammatory process is milder during the acute phase. Besides the moderate course of the disease and pain, decrease in milk production is observed, associated with somewhat altered, watery secretion containing clots. The usual antimicrobial therapy brings no improvement. Somatic cell count is mostly higher than 1 million/ml; however, individual values may range between 6 and 9 millions/ ml (Janosi et al., 1998) , sometimes even exceeding 20 millions/ml (Mali n o w s k i et al., 2002). In that respect, even a limited infection may affect the milk quality within herd. Pursuant to our Regulations on Hygienic Safety of Milk, the threshold value for somatic cell count in hygienically safe milk is 500,000/ml, while regulations of EU countries do not allow values higher then 300,000/ml (Boboš et al., 1997) . If protothecal infection, especially subclinical one, is present in a herd, the somatic cell count in bulk milk samples may be the indicator of the suspect agent.
Since there is neither effective therapy nor spontaneous cure, protothecal infections of the mammary gland become chronic and persist through several lactating periods. Algae are limited to the mammary gland and regional lymph nodes exhibiting granulomatous inflammation. Histological lesions are characterized by massive aggregation of macrophages, plasma cells and lymphocytes (Bobos and Vidić, 2003) . Sporangia and sporangiospores are inside the macrophage and neutrophiles in the alveolar lumen and interstitium, suggesting that intracellular proliferation is responsible for inability to overcome the infection (Janosi et al., 1998) . A pathohistological examination of udder tissue in chronic disease course has revealed the progressive interstitial mastitis with consequent alveolar atrophy (Janosi et al., 2001) . Such changes of the mammary gland result in a progressive drop in milk production (Costa et al., 1997; McDonald et al., 1984b; Tenh age n et al., 1999) .
Attempts to locate sites containing Protothecae in dairy-cow housings have not proved to be successful, as examination of highly-contaminated samples from the environment does not support such measure (www.Uvex.edu/miklquality/prototheca). Cows should be kept out of humid areas, particularly these containing manure and decomposing plant material in order to prevent the papillae from exposure to the infection sources (Costa et al., 1996) . Proper draining system will lower the number of microorganisms in the environment. It is of paramount importance to prevent contact of the teeth ends with feces and moist manure 25-30 minutes after milking because of the relaxed papilla sphincter (Janosi et al., 1998) . If Prototheca is isolated from milk samples, it is recommended to examine all cows in the herd (Hodges et al., 1985) . Similar to the Mycoplasma bovis and Staphylococcus aureus, Protothecae are intermittently shed in the milk (Gonzales, 1996) . As they may be transferred from cow to cow during milking, it is necessary to separate the infected animals and milk them last until final exclusion from the herd (Anderson and Walker, 1998) . Sporadic occurrence of mastitis justifies the culling of infected animals as a measure for prevention of further spread of the infection.
A failure to promptly diagnose the infection and to apply measures for prevention of its spreading inevitably results in the culling of infected animals and decreased milk production and quality, which may cause significant economic losses at dairy farms. The program for mastitis control must include also the Prototheca algae (Schlensted et al., 1997) . Pursuant to legislative regulations in our country, only the exclusion of Staphylococcus aureus and Streptococcus agalactiae is obligatory. As identification of protothecal infections is not a part of routine microbiological examination in veterinary medicine, reports on their occurrence are extremely sporadical (M i 1 a n o v, 2004; M i 1 a n o v, 2005). A more complex diagnostic approach including a longer incubation period and use of restrictive media should become a regular practice in diagnosing clinical and subclinical mastitis (S u v a j d ž i ć et al., 2001a). Milk and dairy products contaminated with P. zopfii are potential sources of human infection. An examination of the susceptibility of 40 strains of P. zopfii isolated from cow milk to different heat-treatment regimens (72-75°C/ 15 sec; 72-75°C/20 sec and 62--65°C/30 minutes) revealed resistance in at least one of the tests in 34 of the examined strains (Melville et al., 1999) .
Diagnosis
Protothecoses are diagnosed by histopathological examination or, more exactly, by isolation of disease agent.
Histopathological examination
Prototheca spp. are haematoxilinophyllic, hence, staining of tissue section by haematoxilin-eosin is not the most appropriate method for their identification. Visualization of the organism is achieved by Gomori-methenarnine silver or periodic acid-schift (PAS) staining techniques when "morulae" are visible, mostly bigger than the ones observed in vitro (10-30 um). Empty sporangia resemble fungi. The sporangia of Prototheca spp. are smaller and contain fewer spores in comparison with Coccidioides immitis and Rhinosporidium seeberi. The organism differs from Blastomyces dermatitidis and Cryptococcus neoformans by the size, internal structure and lack of budding (D i P e r s i o, 2001). For identification of Protothecae in tissue specimens, the immunofluorescency technique is applied (Sudman and Kaplan, 1973) .
Isolation
Prototheca spp. can be recovered (intra vitam) from samples of skin scarificates (cutaneous protothecosis), joint punctuate (bursitis olecranona), feces (hemorrhagic diarrhea in dogs), urine (urinary infections in dogs) and cowmilk (protothecal mastitis). Material is inoculated on blood agar and Sabouraud dextrose agar using standard laboratory techniques. Plates are incubated for 48-72 h at 25-37°C (M i 1 a n o v et al., 2003q).
Cultural and biochemical features
Prototheca spp. grows easily on most standard laboratory nutritive media such as blood agar and Sabouraud-dextrose agar. For isolation from contami-nated samples, application of selective media containing inhibitors of normal microbial flora is recommended. The growth of Prototheca spp. is inhibited by cycloheximide, yet not by hloramphenicol. A special Prototheca medium contains folate for inhibition of bacterial growth and 5-florocytosine for suppression of yeast growth. After incubation for 24-72 h at 25-37°C, visible P. wickerhamii colonies are formed which are smooth, white and yeast-like (D i Persio, 2001 ). Colonies of P. zopfii on Sabouraud-dextrose agar are clearly formed in primary culture after 48-72 hours of incubation. They are mostly large, irregularly margined, with granular surface and a compact central protrusion (Janosi et al., 1998; Milanov et al., 2004) . Colonies grown on blood agar are mostly very small and pale gray (Milanov et al., 2004) . If the isolation medium does not contain growth inhibitors, Prototheca colonies may be overgrown (covered) by bacteria after prolonged incubation (D i P e rs i o, 2001). Since it is slow-growing, the organism may easily be missed in routine practice if incubation is terminated after 24 h (T e n h a g e n et al., 1999). The colonies are of creamy consistency, readily suspended in saline solution when making microscopy slides. Microscopy is indispensable to distinguish Prototheca spp. from yeasts, since differentiation is not possible on the basis of their cultural features.
Characteristic microscopic appearance of Prototheca spp. is best observed by examining native preparations using phase-contrast microscopy, when formations described as "morula" or "mulberry" is visible, Prototheca spp. is easily methyl-blue and Gramm-stained, but heat-fixation may induce morphological impairment. In Gram-stained preparations, positively stained spores and Gram-negative empty sporangia are visible (34). Sporangia of P. wickerhamii are 7-13 urn, of P. zopfii 14-16 um in diameter. Final diagnosis is made by the carbon-hydrate assimilation test (API 20C Bio Merieux; VITEK® Yeast Biochemical Card; RapID Yeast Plus System-Kernel). All Protothecae use glucose as the carbon source. Trechalose assimilation is the key parameter for differentiation between the two pathogenic strains. According to phenotype and genetic criteria, including growth-and biochemical characteristics and serotyping, various isolates of P. zopfii are classified into three biotypes. Biotype II, which ferments glucose and glycerol but not galactose, is mostly isolated in bovine mastitis and human enteropathies (R o e s 1 e r et al., 2003).
Therapy and prognosis
Pharmacological protocol for therapy of this rare infection has not been developed yet either in human or in veterinary medicine. Several antifungal agents are applied for treatment; however, the observed effects are variable. In human medicine, Amphotericin B, a product of Streptornyc.es nodosus (S uv a j d ž i ć, 2004), is used for therapy of disseminated protothecosis. This is a funghistatic or fungicide that inhibits ergosterole synthesis in the cell membrane of Prototheca spp. The drug has proven to be nephrotoxic, and confirmed oversusceptibility is contraindication to its use. Administration of immidazoles, such as itracosanole, ketoconasole, fluconasole and clorimazole, may show so-me improvement; however, their efficacy is not yet confirmed due to variable clinical response. Where possible, surgical excision is the treatment of choice. Prognosis is promising in patients with localized infection, and healing is often achieved. Prognosis is less predictable, mostly bad, in patients with other diseases and in immunocompromised patients.
Therapy of systemic protothecosis in dogs may include amphotericin B, tetracyclin, ketoconasole, itraconasole, fluconasole and chorimazole; however, outcomes of such therapies are not yet established. Cutaneous protothecosis caused by P. wickerhamii requires both medicamentous treatment and surgical excision.
In vitro isolates of P. zopfii from milk exhibited sensitivity to amphothericin B, nystatin, polymyxin B, gentamicin and neomycin (McDonald et al., 1984b; Malinowski et al., 2002) . Effective therapy of protothecal mastitis has not yet been developed and the only measure to control the spread of infection in the herd is exclusion of infected animals.
Sensitivity of Prototheca spp. in vitro does not necessarily correlate with its efficacy in vivo.
